Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Jarvis

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2015
Editor's NoteMichael F Jarvis
Purinergic Signalling|October 8, 2020
Geoffery Burnstock's influence on the evolution of P2X3 receptor pharmacologyMichael F Jarvis
Pharmacology Research & Perspectives|August 2, 2019
Therapeutic potential of adenosine kinase inhibition-RevisitedMichael F Jarvis
Expert Opinion on Therapeutic Targets|July 30, 2003
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic painMichael F Jarvis
Current Protocols in Pharmacology|February 11, 2014
Characterization of P1 (adenosine) purinoceptorsMichael F Jarvis
Trends in Neurosciences|November 17, 2009
The neural-glial purinergic receptor ensemble in chronic pain statesMichael F Jarvis
Pain|June 12, 2012
Cytochrome P450 mediated linoleic acid metabolism in peripheral inflammatory nociceptionMichael F Jarvis
Biochemical Pharmacology|February 26, 2024
Decatastrophizing research irreproducibilityMichael F Jarvis
Trends in Pharmacological Sciences|January 19, 2016
Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge GapsMichael F Jarvis, Michael Williams
Current Protocols in Pharmacology|February 2, 2012
Electrophysiological characterization of recombinant and native P2X receptorsWende Niforatos, Michael F Jarvis
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2015
Editor's NoteMichael F Jarvis
Purinergic Signalling|October 8, 2020
Geoffery Burnstock's influence on the evolution of P2X3 receptor pharmacologyMichael F Jarvis
Pharmacology Research & Perspectives|August 2, 2019
Therapeutic potential of adenosine kinase inhibition-RevisitedMichael F Jarvis
Expert Opinion on Therapeutic Targets|July 30, 2003
Contributions of P2X3 homomeric and heteromeric channels to acute and chronic painMichael F Jarvis
Current Protocols in Pharmacology|February 11, 2014
Characterization of P1 (adenosine) purinoceptorsMichael F Jarvis
Trends in Neurosciences|November 17, 2009
The neural-glial purinergic receptor ensemble in chronic pain statesMichael F Jarvis
Pain|June 12, 2012
Cytochrome P450 mediated linoleic acid metabolism in peripheral inflammatory nociceptionMichael F Jarvis
Biochemical Pharmacology|February 26, 2024
Decatastrophizing research irreproducibilityMichael F Jarvis
Trends in Pharmacological Sciences|January 19, 2016
Irreproducibility in Preclinical Biomedical Research: Perceptions, Uncertainties, and Knowledge GapsMichael F Jarvis, Michael Williams
Current Protocols in Pharmacology|February 2, 2012
Electrophysiological characterization of recombinant and native P2X receptorsWende Niforatos, Michael F Jarvis
Pageof 13